Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$863,334,513
+$117,415,542 QoQ
Shares Held
930,548
-8.9% QoQ
Ownership
1.50%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#7
of 504 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 83%
None 17%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. ARGX ranks #2 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
This page
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in ARGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $863,334,513 | 930,548 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $745,918,971 | 1,021,457 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $571,203,510 | 679,236 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $538,408,468 | 729,986 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $223,427,651 | 405,333 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $240,417,926 | 406,204 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $261,359,010 | 424,974 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $261,470,117 | 482,346 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $183,510,537 | 426,729 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $108,734,436 | 276,172 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $106,203,879 | 279,168 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $108,754,452 | 221,212 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $91,218,253 | 234,055 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $96,228,470 | 258,276 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $83,596,035 | 220,669 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $76,115,107 | 215,593 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $19,696,074 | 51,985 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $75,204,900 | 238,511 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $139,735,610 | 399,028 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $201,946,192 | 668,696 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $168,101,527 | 558,347 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $142,765,754 | 518,413 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $181,299,126 | 616,475 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $278,364,128 | 1,060,354 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $143,726,242 | 638,131 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $90,701,634 | 688,542 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||